Structural biology in drug discovery: methods, techniques, and practices
"This book acts as a comprehensive guide about the principles, methods, and applications of structure-based drug discovery. It includes successful examples as well as recent developments in the field. Part 1 of the book covers necessary information and concepts of applying structural biology in...
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Hoboken, NJ
Wiley
2020
|
Schlagworte: | |
Online-Zugang: | DE-188 DE-29 Volltext |
Zusammenfassung: | "This book acts as a comprehensive guide about the principles, methods, and applications of structure-based drug discovery. It includes successful examples as well as recent developments in the field. Part 1 of the book covers necessary information and concepts of applying structural biology in the drug discovery process. It provides experimental and computational approaches to drug characterization and evaluation, an overview of fragment-based drug design, and a description of how to combine structural, thermodynamic and kinetic information for hit-to-lead drug development. Part 2 covers novel tools and techniques related to drug discovery, like automated platforms for protein characterization, various types of crystallizations, and high-throughput crystallography. Part 3 features case studies of structure-based discovery on important, established but still challenging therapeutic target families, as well as on monoclonal antibodies as an example of biotherapeutics. The final section illustrates new frontiers and challenges in the field, like intrinsically disordered proteins, neglected diseases, or viral resistance, and promising techniques for the future (XFELs and cryo-EM). Altogether, this book is an up-to-date resource about structure-based drug discovery that provides academic and industry insights, novel concepts, and advances in a fast-growing field"--Provided by publisher |
Beschreibung: | 1 Online-Ressource (xxviii, 660 Seiten, 9 ungezählte Seiten) Illustrationen, Diagramme |
ISBN: | 9781118681121 9781118900505 9781118900406 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV047180671 | ||
003 | DE-604 | ||
005 | 20250121 | ||
007 | cr|uuu---uuuuu | ||
008 | 210308s2020 xx a||| ob||| 00||| eng d | ||
020 | |a 9781118681121 |c Online |9 978-1-118-68112-1 | ||
020 | |a 9781118900505 |c EPUB |9 978-1-118-90050-5 | ||
020 | |a 9781118900406 |c PDF |9 978-1-118-90040-6 | ||
035 | |a (OCoLC)1196871153 | ||
035 | |a (DE-599)BVBBV047180671 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-29 |a DE-188 | ||
084 | |a VS 5350 |0 (DE-625)147687:253 |2 rvk | ||
245 | 1 | 0 | |a Structural biology in drug discovery |b methods, techniques, and practices |c edited by Jean-Paul Renaud (President & CSO at Urania Therapeutics, Ostwald, France, Cofounder at NovAliX, Illkirch, France, CNRS Research Director at IGBMC, Illkirch, France) |
264 | 1 | |a Hoboken, NJ |b Wiley |c 2020 | |
300 | |a 1 Online-Ressource (xxviii, 660 Seiten, 9 ungezählte Seiten) |b Illustrationen, Diagramme | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | 3 | |a "This book acts as a comprehensive guide about the principles, methods, and applications of structure-based drug discovery. It includes successful examples as well as recent developments in the field. Part 1 of the book covers necessary information and concepts of applying structural biology in the drug discovery process. It provides experimental and computational approaches to drug characterization and evaluation, an overview of fragment-based drug design, and a description of how to combine structural, thermodynamic and kinetic information for hit-to-lead drug development. Part 2 covers novel tools and techniques related to drug discovery, like automated platforms for protein characterization, various types of crystallizations, and high-throughput crystallography. Part 3 features case studies of structure-based discovery on important, established but still challenging therapeutic target families, as well as on monoclonal antibodies as an example of biotherapeutics. The final section illustrates new frontiers and challenges in the field, like intrinsically disordered proteins, neglected diseases, or viral resistance, and promising techniques for the future (XFELs and cryo-EM). Altogether, this book is an up-to-date resource about structure-based drug discovery that provides academic and industry insights, novel concepts, and advances in a fast-growing field"--Provided by publisher | |
650 | 0 | 7 | |a Strukturbiologie |0 (DE-588)1081522143 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |2 gnd |9 rswk-swf |
653 | 0 | |a Drug Discovery / methods | |
653 | 0 | |a Molecular Biology / methods | |
653 | 0 | |a Genetic Techniques | |
653 | 0 | |a Drug Design | |
689 | 0 | 0 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |D s |
689 | 0 | 1 | |a Strukturbiologie |0 (DE-588)1081522143 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Renaud, Jean-Paul |d 1960- |0 (DE-588)1207794678 |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-1-118-68112-1 |
856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781118681121 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-032585966 | |
966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781118681121 |l DE-188 |p ZDB-35-WIC |q ZDB-35-WIC 2023 |x Verlag |3 Volltext | |
966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781118681121 |l DE-29 |p ZDB-35-WIC |q UER_PDA_WIC_Kauf |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1823676334087340032 |
---|---|
adam_text | |
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author2 | Renaud, Jean-Paul 1960- |
author2_role | edt |
author2_variant | j p r jpr |
author_GND | (DE-588)1207794678 |
author_facet | Renaud, Jean-Paul 1960- |
building | Verbundindex |
bvnumber | BV047180671 |
classification_rvk | VS 5350 |
ctrlnum | (OCoLC)1196871153 (DE-599)BVBBV047180671 |
discipline | Chemie / Pharmazie |
discipline_str_mv | Chemie / Pharmazie |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV047180671</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20250121</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">210308s2020 xx a||| ob||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118681121</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-118-68112-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118900505</subfield><subfield code="c">EPUB</subfield><subfield code="9">978-1-118-90050-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118900406</subfield><subfield code="c">PDF</subfield><subfield code="9">978-1-118-90040-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1196871153</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047180671</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5350</subfield><subfield code="0">(DE-625)147687:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Structural biology in drug discovery</subfield><subfield code="b">methods, techniques, and practices</subfield><subfield code="c">edited by Jean-Paul Renaud (President & CSO at Urania Therapeutics, Ostwald, France, Cofounder at NovAliX, Illkirch, France, CNRS Research Director at IGBMC, Illkirch, France)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, NJ</subfield><subfield code="b">Wiley</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xxviii, 660 Seiten, 9 ungezählte Seiten)</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"This book acts as a comprehensive guide about the principles, methods, and applications of structure-based drug discovery. It includes successful examples as well as recent developments in the field. Part 1 of the book covers necessary information and concepts of applying structural biology in the drug discovery process. It provides experimental and computational approaches to drug characterization and evaluation, an overview of fragment-based drug design, and a description of how to combine structural, thermodynamic and kinetic information for hit-to-lead drug development. Part 2 covers novel tools and techniques related to drug discovery, like automated platforms for protein characterization, various types of crystallizations, and high-throughput crystallography. Part 3 features case studies of structure-based discovery on important, established but still challenging therapeutic target families, as well as on monoclonal antibodies as an example of biotherapeutics. The final section illustrates new frontiers and challenges in the field, like intrinsically disordered proteins, neglected diseases, or viral resistance, and promising techniques for the future (XFELs and cryo-EM). Altogether, this book is an up-to-date resource about structure-based drug discovery that provides academic and industry insights, novel concepts, and advances in a fast-growing field"--Provided by publisher</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Strukturbiologie</subfield><subfield code="0">(DE-588)1081522143</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drug Discovery / methods</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Molecular Biology / methods</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Genetic Techniques</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drug Design</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Strukturbiologie</subfield><subfield code="0">(DE-588)1081522143</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Renaud, Jean-Paul</subfield><subfield code="d">1960-</subfield><subfield code="0">(DE-588)1207794678</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-1-118-68112-1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9781118681121</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032585966</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9781118681121</subfield><subfield code="l">DE-188</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">ZDB-35-WIC 2023</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9781118681121</subfield><subfield code="l">DE-29</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UER_PDA_WIC_Kauf</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV047180671 |
illustrated | Illustrated |
index_date | 2024-07-03T16:45:51Z |
indexdate | 2025-02-10T13:14:41Z |
institution | BVB |
isbn | 9781118681121 9781118900505 9781118900406 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032585966 |
oclc_num | 1196871153 |
open_access_boolean | |
owner | DE-29 DE-188 |
owner_facet | DE-29 DE-188 |
physical | 1 Online-Ressource (xxviii, 660 Seiten, 9 ungezählte Seiten) Illustrationen, Diagramme |
psigel | ZDB-35-WIC ZDB-35-WIC 2023 ZDB-35-WIC UER_PDA_WIC_Kauf |
publishDate | 2020 |
publishDateSearch | 2020 |
publishDateSort | 2020 |
publisher | Wiley |
record_format | marc |
spelling | Structural biology in drug discovery methods, techniques, and practices edited by Jean-Paul Renaud (President & CSO at Urania Therapeutics, Ostwald, France, Cofounder at NovAliX, Illkirch, France, CNRS Research Director at IGBMC, Illkirch, France) Hoboken, NJ Wiley 2020 1 Online-Ressource (xxviii, 660 Seiten, 9 ungezählte Seiten) Illustrationen, Diagramme txt rdacontent c rdamedia cr rdacarrier "This book acts as a comprehensive guide about the principles, methods, and applications of structure-based drug discovery. It includes successful examples as well as recent developments in the field. Part 1 of the book covers necessary information and concepts of applying structural biology in the drug discovery process. It provides experimental and computational approaches to drug characterization and evaluation, an overview of fragment-based drug design, and a description of how to combine structural, thermodynamic and kinetic information for hit-to-lead drug development. Part 2 covers novel tools and techniques related to drug discovery, like automated platforms for protein characterization, various types of crystallizations, and high-throughput crystallography. Part 3 features case studies of structure-based discovery on important, established but still challenging therapeutic target families, as well as on monoclonal antibodies as an example of biotherapeutics. The final section illustrates new frontiers and challenges in the field, like intrinsically disordered proteins, neglected diseases, or viral resistance, and promising techniques for the future (XFELs and cryo-EM). Altogether, this book is an up-to-date resource about structure-based drug discovery that provides academic and industry insights, novel concepts, and advances in a fast-growing field"--Provided by publisher Strukturbiologie (DE-588)1081522143 gnd rswk-swf Arzneimittelforschung (DE-588)4003120-2 gnd rswk-swf Drug Discovery / methods Molecular Biology / methods Genetic Techniques Drug Design Arzneimittelforschung (DE-588)4003120-2 s Strukturbiologie (DE-588)1081522143 s DE-604 Renaud, Jean-Paul 1960- (DE-588)1207794678 edt Erscheint auch als Druck-Ausgabe, Hardcover 978-1-118-68112-1 https://onlinelibrary.wiley.com/doi/book/10.1002/9781118681121 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Structural biology in drug discovery methods, techniques, and practices Strukturbiologie (DE-588)1081522143 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
subject_GND | (DE-588)1081522143 (DE-588)4003120-2 |
title | Structural biology in drug discovery methods, techniques, and practices |
title_auth | Structural biology in drug discovery methods, techniques, and practices |
title_exact_search | Structural biology in drug discovery methods, techniques, and practices |
title_exact_search_txtP | Structural biology in drug discovery methods, techniques, and practices |
title_full | Structural biology in drug discovery methods, techniques, and practices edited by Jean-Paul Renaud (President & CSO at Urania Therapeutics, Ostwald, France, Cofounder at NovAliX, Illkirch, France, CNRS Research Director at IGBMC, Illkirch, France) |
title_fullStr | Structural biology in drug discovery methods, techniques, and practices edited by Jean-Paul Renaud (President & CSO at Urania Therapeutics, Ostwald, France, Cofounder at NovAliX, Illkirch, France, CNRS Research Director at IGBMC, Illkirch, France) |
title_full_unstemmed | Structural biology in drug discovery methods, techniques, and practices edited by Jean-Paul Renaud (President & CSO at Urania Therapeutics, Ostwald, France, Cofounder at NovAliX, Illkirch, France, CNRS Research Director at IGBMC, Illkirch, France) |
title_short | Structural biology in drug discovery |
title_sort | structural biology in drug discovery methods techniques and practices |
title_sub | methods, techniques, and practices |
topic | Strukturbiologie (DE-588)1081522143 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
topic_facet | Strukturbiologie Arzneimittelforschung |
url | https://onlinelibrary.wiley.com/doi/book/10.1002/9781118681121 |
work_keys_str_mv | AT renaudjeanpaul structuralbiologyindrugdiscoverymethodstechniquesandpractices |